Synoptic announces strategic partnership with Professor Sebastian Johnston’s Virtus-RR

Synoptic is pleased to announce they have entered into strategic partnerships with Professor Sebastian Johnston’s Virtus-RR, a union that combines Synoptic’s industry-leading data management software with the world-class SARS-CoV-2 Quantitive Antibody testing services.

With technology playing an increasingly critical role in every aspect of the Covid pandemic, Synoptic has recognised the need to accelerate the development of digital solutions so that we can overcome the virus as quickly as possible. The Synoptic-Virtus partnership brings together deep skills in data management and testing solutions that will help to support the public through these unprecedented times.

Synoptic’s understanding of complex digital interactions, its deep engineering expertise, and collaborative approach is uniquely complimentary to the operations of Virtus-RR. We believe that by providing testing as a service and aggregating and managing the relevant data associated with a positive test result we can not only protect people as they resume their daily lives but can also start to understand the virus and stop it in its tracks.

Graeme Scott, Founder and CEO of Synoptic said “The work undertaken by Professor Sebastian Johnston and Virtus RR is amongst the best in the world in the field of Antibody testing, founded on many decades of research, experience and expertise. We are delighted to align our Antibody approach with the best of breed which the Virtus test clearly represent. To unlock our lives and regain a semblance of normality will require regular Antibody testing to identify and map the efficacy of the various vaccines coming to market, Virtus play a huge role with this process.”